16th Feb 2016 1:58 pm |
RNS |
Private Placement |
11th Feb 2016 3:30 pm |
RNS |
Phase III studies update |
28th Jan 2016 10:28 am |
RNS |
Excellent results in Ameluz BCC clinical study |
26th Jan 2016 9:49 am |
RNS |
FDA completes Ameluz NDA mid-cycle review |
20th Jan 2016 7:00 am |
RNS |
Notice of Cancellation from Trading on AIM |
7th Jan 2016 7:00 am |
RNS |
CE Marking Granted for IndoorLux® Collaboration |
31st Dec 2015 11:57 am |
RNS |
Total Voting Rights |
23rd Dec 2015 2:30 pm |
RNS |
FDA Grants Small Business Waiver of US$2.3m |
10th Dec 2015 7:00 am |
RNS |
Issue of equity and total voting rights |
7th Dec 2015 7:00 am |
RNS |
Marketing approval for Ameluz® in Switzerland |
23rd Nov 2015 3:05 pm |
RNS |
Result of Open Offer and Private Placement |
20th Nov 2015 7:00 am |
RNS |
3rd Quarter Report |
19th Nov 2015 8:00 am |
RNS |
Final patient visit in Phase III trial for BCC |
12th Nov 2015 1:00 pm |
RNS |
Notice of Q3 Results |
11th Nov 2015 12:00 pm |
RNS |
Business Operations on Track |
5th Nov 2015 11:32 am |
RNS |
Further re: Subscription Price of New Shares |
28th Oct 2015 3:23 pm |
RNS |
Further re: Open Offer and Private Placement |
27th Oct 2015 11:31 am |
RNS |
Open Offer and Private Placement |
2nd Oct 2015 7:00 am |
RNS |
FDA shortens review period for Ameluz |
22nd Sep 2015 7:00 am |
RNS |
Excellent long term results of Phase III trial |
14th Sep 2015 7:00 am |
RNS |
FDA accepts filing of Ameluz® and BF-RhodoLED® |
1st Sep 2015 7:03 am |
RNS |
Result of AGM |
14th Aug 2015 7:00 am |
RNS |
Half Year Results |
7th Aug 2015 7:00 am |
RNS |
Notice of Results |
22nd Jul 2015 7:00 am |
RNS |
Appointment of Chief Commercial Officer |
20th Jul 2015 7:00 am |
RNS |
Belixos® Protect product launch |
17th Jul 2015 7:00 am |
RNS |
Notice of AGM |
13th Jul 2015 9:45 am |
RNS |
FDA New Drug Application submitted for Ameluz® |
22nd Jun 2015 7:00 am |
RNS |
Final stage completed ahead of FDA submission |
19th Jun 2015 6:10 pm |
RNS |
Issue of equity and total voting rights |
29th May 2015 7:00 am |
RNS |
Strong Performance for Q1 2015 |
28th May 2015 7:00 am |
RNS |
Result of Open Offer & Private Placement |
26th May 2015 7:01 am |
RNS |
Notice of First Quarter Results 2015 |
6th May 2015 7:02 am |
RNS |
Publication of PIII Study for Actinic Keratosis |
27th Apr 2015 2:58 pm |
RNS |
Further re Open Offer and Private Placement |
23rd Apr 2015 1:36 pm |
RNS |
Open Offer and Private Placement |
20th Apr 2015 7:00 am |
RNS |
US subsidiary and CEO US Operations Appointed |
17th Apr 2015 7:00 am |
RNS |
Q1 Preliminary Trading Update |
10th Apr 2015 7:00 am |
RNS |
Final Results |
8th Apr 2015 7:00 am |
RNS |
Off Market Block Trade Completed |